Observations placeholder
Gilenya
Identifier
019089
Type of Spiritual Experience
Background
A description of the experience
Fingolimod (INN, trade name Gilenya, Novartis) is an immunomodulating drug, mostly used for treating multiple sclerosis (MS) . Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.
Fingolimod is used in the treatment of the relapsing form of multiple sclerosis. Its effect in those with primary progressive MS is not clear. May also be used in chronic inflammatory demyelinating polyneuropathy.
Side effects
The most common side effects of fingolimod have been head colds, headache, and fatigue. A few cases of skin cancer have been reported, which has also been reported in patients taking natalizumab (Tysabri), an approved MS drug Fingolimod has also been associated with potentially fatal infections, bradycardia and, recently, a case of hemorrhaging focal encephalitis, an inflammation of the brain with bleeding Two people died: one due to brain herpes infection, and a second one due to zoster. It is unclear whether the drug was responsible for the events.At least three cases of progressive multifocal leukoencephalopathy had also occurred as of 2015
On Dec, 29, 2016 37,789 people reported to have side effects when taking Gilenya.
Among them, 92 people (0.24%) have Hallucination
Time on Gilenya when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination40.00%10.00%50.00%0.00%0.00%0.00%0.00
On Dec, 21, 2015: 10,372 people reported to have side effects when taking Gilenya. Among them, 113 people (1.09%) have Death.
Time on Gilenya when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death16.67%75.00%8.33%0.00%0.00%0.00%0.00%